KORE (NYSE:KORE) suspended financial guidance for the remainder of fiscal year 2025 due to uncertainty from the announced ...
Continued execution on collaborations and exploratory investigator-initiated studies with institutional partners ...
The growing incidence of multidrug-resistant (MDR) or extensively-drug resistant (XDR) bacteria is an emerging challenge in modern medicine. Constant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback